NO20030081D0 - Anvendelse av stammer fra parapoxvirus mot organfibroser - Google Patents

Anvendelse av stammer fra parapoxvirus mot organfibroser

Info

Publication number
NO20030081D0
NO20030081D0 NO20030081A NO20030081A NO20030081D0 NO 20030081 D0 NO20030081 D0 NO 20030081D0 NO 20030081 A NO20030081 A NO 20030081A NO 20030081 A NO20030081 A NO 20030081A NO 20030081 D0 NO20030081 D0 NO 20030081D0
Authority
NO
Norway
Prior art keywords
organ fibrosis
strains against
against organ
parapoxvirus
parapoxvirus strains
Prior art date
Application number
NO20030081A
Other languages
English (en)
Other versions
NO20030081L (no
Inventor
Claudia Hirth-Dietrich
Tobias Schlapp
Angela Siegling
Andreas Knorr
Olaf Weber
Gudrun Theiss
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10122233A external-priority patent/DE10122233A1/de
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO20030081L publication Critical patent/NO20030081L/no
Publication of NO20030081D0 publication Critical patent/NO20030081D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24211—Parapoxvirus, e.g. Orf virus
    • C12N2710/24232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Psychiatry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20030081A 2000-07-11 2003-01-08 Anvendelse av stammer fra parapoxvirus mot organfibroser NO20030081D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10033581 2000-07-11
DE10122233A DE10122233A1 (de) 2000-07-11 2001-05-08 Verwendung von Stämmen des Parapoxvirus ovis gegen Organfibrosen
PCT/EP2001/007978 WO2002004019A2 (de) 2000-07-11 2001-07-11 Verwendung von stämmen des parapoxvirus ovis gegen organfibrosen

Publications (2)

Publication Number Publication Date
NO20030081L NO20030081L (no) 2003-01-08
NO20030081D0 true NO20030081D0 (no) 2003-01-08

Family

ID=26006334

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030081A NO20030081D0 (no) 2000-07-11 2003-01-08 Anvendelse av stammer fra parapoxvirus mot organfibroser

Country Status (30)

Country Link
US (1) US6632647B2 (no)
EP (1) EP1303302B1 (no)
JP (1) JP5106736B2 (no)
CN (1) CN1452496B (no)
AR (1) AR028800A1 (no)
AU (2) AU2001285827B2 (no)
BG (1) BG107447A (no)
CA (1) CA2415399C (no)
CZ (1) CZ200372A3 (no)
DK (1) DK200300014A (no)
EE (1) EE200300019A (no)
FI (1) FI20030038A (no)
GB (1) GB2383752B (no)
HK (1) HK1054330B (no)
HR (1) HRP20030097A2 (no)
HU (1) HU227668B1 (no)
IL (1) IL153826A0 (no)
LT (1) LT5064B (no)
LU (1) LU90996B1 (no)
LV (1) LV12991B (no)
MA (1) MA25765A1 (no)
MX (1) MXPA03000278A (no)
NO (1) NO20030081D0 (no)
NZ (1) NZ523535A (no)
PL (1) PL360839A1 (no)
RU (1) RU2003104522A (no)
SE (1) SE0300033L (no)
SI (1) SI21171A (no)
SK (1) SK382003A3 (no)
WO (1) WO2002004019A2 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19922407A1 (de) * 1999-05-14 2000-11-16 Bayer Ag Organ-, gewebs- und zellspezifisches Immuntherapeutikum für chronische virale Infektionen, sowie entzündliche, degenerative und proliferative Erkrankungen insbesondere der Leber sowie Krebs auf der Basis von rekombinantem Parapoxvirus
WO2003049683A2 (en) 2001-12-07 2003-06-19 Bayer Pharmacueticals Corporation Use of parapox b2l protein to treat cancer and modify immune responses
US6752995B2 (en) * 2002-04-15 2004-06-22 Board Of Regents, The University Of Texas System Nucleic acid and polypeptide sequences useful as adjuvants
EP1574211A1 (en) 2004-03-09 2005-09-14 Inserm Use of antagonists of the CB1 receptor for the manufacture of a composition useful for the treatment of hepatic diseases
WO2012045473A1 (en) * 2010-10-07 2012-04-12 Technische Universität München Viruses for the treatment of fibrosis
KR20180129779A (ko) * 2016-02-16 2018-12-05 고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸 섬유화를 치료하기 위한 의약 조성물
TW201919675A (zh) * 2017-09-07 2019-06-01 德商艾庫瑞斯公司 使用羊副痘疹病毒(Parapoxvirus ovis；PPVO)及至少一種額外抗病毒藥之經B型肝炎病毒(HBV)感染之個體之組合療法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714665A1 (de) * 1977-04-01 1978-10-05 Mayr Anton Praeparat zur behandlung von herpes zoster und anderen herpes-infektionen, sowie verfahren zu seiner herstellung
US4360510A (en) * 1979-11-30 1982-11-23 Proctor Julian W Method for screening anti-tumor agents of the reticulo-endothelial stimulant class
US4663306A (en) * 1983-09-23 1987-05-05 Ribi Immunochem Research, Inc. Pyridine-soluble extract-refined detoxified endotoxin composition and use
DE3504940C2 (de) 1984-02-17 1997-11-06 Bayer Ag Multipotente Paramunitätsmediatoren, Verfahren zu ihrer Herstellung und diese Mediatoren enthaltende Arzneimittel
DE3816139A1 (de) * 1987-10-17 1989-04-27 Bayer Ag Verfahren zur herstellung von paramunitaetsinducern
DE4405841C1 (de) 1994-02-23 1995-01-05 Mayr Anton Prof Dr Med Vet Dr Multipotente Paramunitätsinducer auf der Basis von Kombinationen von Pockenviruskomponenten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
BR9708679A (pt) * 1996-04-15 2000-01-04 Anton Mayr Uso de indutores de pox, e, processo para tratamento auxiliar de pacientes submetidos à quimioterapia ou radioterapia.
DE19922407A1 (de) * 1999-05-14 2000-11-16 Bayer Ag Organ-, gewebs- und zellspezifisches Immuntherapeutikum für chronische virale Infektionen, sowie entzündliche, degenerative und proliferative Erkrankungen insbesondere der Leber sowie Krebs auf der Basis von rekombinantem Parapoxvirus
IL139593A (en) * 2000-11-09 2010-12-30 Biogem Optical Ltd Method for the detection of viable microorganisms

Also Published As

Publication number Publication date
US6632647B2 (en) 2003-10-14
EP1303302B1 (de) 2009-10-14
MA25765A1 (fr) 2003-04-01
LV12991B (en) 2003-08-20
AU8582701A (en) 2002-01-21
IL153826A0 (en) 2003-07-31
AU2001285827B2 (en) 2006-11-30
DK200300014A (da) 2003-03-07
LT2003008A (en) 2003-07-25
JP5106736B2 (ja) 2012-12-26
PL360839A1 (en) 2004-09-20
FI20030038A (fi) 2003-03-10
LU90996B1 (en) 2003-01-08
SE0300033D0 (sv) 2003-01-10
HK1054330B (zh) 2005-07-15
RU2003104522A (ru) 2004-06-27
NO20030081L (no) 2003-01-08
GB2383752B (en) 2004-11-24
EE200300019A (et) 2004-10-15
MXPA03000278A (es) 2004-04-05
US20020076418A1 (en) 2002-06-20
CZ200372A3 (cs) 2003-05-14
WO2002004019A3 (de) 2002-08-01
SE0300033L (sv) 2003-03-10
BG107447A (bg) 2003-09-30
CA2415399A1 (en) 2003-01-08
HU227668B1 (en) 2011-11-28
HK1054330A1 (en) 2003-11-28
HUP0303830A2 (hu) 2004-04-28
AR028800A1 (es) 2003-05-21
CA2415399C (en) 2011-11-08
SK382003A3 (en) 2003-07-01
WO2002004019A2 (de) 2002-01-17
NZ523535A (en) 2004-12-24
GB2383752A (en) 2003-07-09
CN1452496A (zh) 2003-10-29
SI21171A (sl) 2003-10-31
JP2004502741A (ja) 2004-01-29
GB0302629D0 (en) 2003-03-12
HRP20030097A2 (en) 2005-02-28
HUP0303830A3 (en) 2004-10-28
EP1303302A2 (de) 2003-04-23
CN1452496B (zh) 2012-10-10
LT5064B (lt) 2003-11-25

Similar Documents

Publication Publication Date Title
EE05145B1 (et) Kombineeritud pallipress/pallim„hkur
DE50103027D1 (de) Generische wlan-architektur
DE60119264D1 (de) Momentwiderstehende Bandverbindung
NO20023850L (no) Kompositt piezoelektrisk transformator
DE60107598D1 (de) Smart-skin strukturen
ATE279238T1 (de) Gewichtsmanschette
DE60109319D1 (de) Manchette
AU2002216622A1 (en) Dynamic organ function monitoring agents
ATE332895T1 (de) Tetrazolderivate
DE60101411D1 (de) Endoskopische Bildaufnahmeanordnung
NO20030081D0 (no) Anvendelse av stammer fra parapoxvirus mot organfibroser
ATE366244T1 (de) Tetrazolderivate
AU2001285827A2 (en) Use of strains of the parapox ovis virus against organ fibrosis
AU2001285827A1 (en) Use of strains of the parapox ovis virus against organ fibrosis
GB0001475D0 (en) Virus strains
ITRM20010295A1 (it) Metodo per ottenere microrganismi patogeni non virulenti attraverso una modificazione dello stato fisico e/o dinamico delle loro membrane bi
FR2814960B3 (fr) Corde de raquette
SE0002921D0 (sv) Pharmaceutically useful compounds
SE0004458D0 (sv) Pharmaceutically useful compounds
FR2810296B3 (fr) La propulsion cyclonale
TW427152U (en) Improved structure of stethoscope
TW424497U (en) Improved structure of stethoscope
SE0000645D0 (sv) New pharmaceutically active compounds
ES1046660Y (es) Yoyo desmontable
TW488540U (en) Improved structure of buzzer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application